Literature DB >> 7585613

Increase in suprabasilar integrin adhesion molecule expression in human epidermal neoplasms accompanies increased proliferation occurring with immortalization and tumor progression.

C Van Waes1, D M Surh, Z Chen, M Kirby, J S Rhim, R Brager, R B Sessions, J Poore, G T Wolf, T E Carey.   

Abstract

In a previous prospective study of 80 patients with squamous cell carcinoma of the upper aerodigestive tract, a progressive increase in expression of the integrin cell adhesion molecule alpha 6 beta 4 in suprabasilar cell layers of the tumor parenchyma was associated with an increase in early recurrence after therapy. In this study, we determined the relationship of the altered expression pattern of the integrin to changes occurring during benign, invasive, or metastatic stages of tumor development. Suprabasilar expression of integrin alpha 6 beta 4 appeared with neoplastic transformation in benign squamous papillomas, but homogeneous expression occurred more frequently in the parenchyma of primary and metastatic squamous cell carcinomas. The variation in the extent of suprabasilar integrin expression among the tumors corresponded to the variation in the population undergoing proliferation as determined by two independent markers of proliferation. Integrin expression was quantified in primary, HPV 16 DNA-immortalized, and v-ki-ras oncogene-transformed keratinocytes, and the pattern of expression was compared with cell cycle progression. Primary keratinocyte lines showed a bimodal distribution of integrin expression, with one population showing decreased integrin expression, cell size, and a block of cell cycle progression consistent with differentiation, whereas another population exhibited high integrin expression and full progression through the cell cycle, consistent with proliferation. HPV-immortalized and v-ki-ras-transformed cell lines undergoing continuous proliferation exhibited uniformly strong integrin expression, which was similar in intensity to that observed in the proliferating population of normal keratinocytes. Similar increases in expression of two additional integrins, alpha 2 beta 1 and alpha 3 beta 1, occurred along with integrin alpha 6 beta 4 in tissue specimens and cell lines derived from neoplasms. Thus, epidermal neoplasms display an increase in a population of cells exhibiting constitutive expression of a repertoire of integrins, which is similar to that found transiently in the acute phase of epidermal wound healing, a physiological response in which hyperproliferation, retention of multiple layers of proliferating cells, and migration occur. The association of a progressive increase in suprabasilar expression of these integrins with early tumor recurrence and advanced neoplasia suggests that constitutive expression and function of the same repertoire of integrins may be advantageous, rather than sufficient, for tumor progression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585613

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Possible involvement of TWIST in enhanced peritoneal metastasis of epithelial ovarian carcinoma.

Authors:  Mikio Terauchi; Hiroaki Kajiyama; Mamoru Yamashita; Mikihiko Kato; Hirohisa Tsukamoto; Tomokazu Umezu; Satoyo Hosono; Eiko Yamamoto; Kiyosumi Shibata; Kazuhiko Ino; Akihiro Nawa; Tetsuro Nagasaka; Fumitaka Kikkawa
Journal:  Clin Exp Metastasis       Date:  2007-05-09       Impact factor: 5.150

2.  Phosphorylation of a novel site on the {beta}4 integrin at the trailing edge of migrating cells promotes hemidesmosome disassembly.

Authors:  Emily C Germain; Tanya M Santos; Isaac Rabinovitz
Journal:  Mol Biol Cell       Date:  2008-11-12       Impact factor: 4.138

3.  Metastatic variants derived following in vivo tumor progression of an in vitro transformed squamous cell carcinoma line acquire a differential growth advantage requiring tumor-host interaction.

Authors:  Z Chen; C W Smith; D Kiel; C Van Waes
Journal:  Clin Exp Metastasis       Date:  1997-09       Impact factor: 5.150

4.  The pivotal role of integrin β1 in metastasis of head and neck squamous cell carcinoma.

Authors:  Dongsheng Wang; Susan Müller; A R M Ruhul Amin; Donghai Huang; Ling Su; Zhongliang Hu; Mohammad Aminur Rahman; Sreenivas Nannapaneni; Lydia Koenig; Zhengjia Chen; Mourad Tighiouart; Dong M Shin; Zhuo G Chen
Journal:  Clin Cancer Res       Date:  2012-07-24       Impact factor: 12.531

5.  ΔNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation.

Authors:  Xinping Yang; Hai Lu; Bin Yan; Rose-Anne Romano; Yansong Bian; Jay Friedman; Praveen Duggal; Clint Allen; Ryan Chuang; Reza Ehsanian; Han Si; Satrajit Sinha; Carter Van Waes; Zhong Chen
Journal:  Cancer Res       Date:  2011-05-15       Impact factor: 12.701

6.  Loss of integrin α3 prevents skin tumor formation by promoting epidermal turnover and depletion of slow-cycling cells.

Authors:  Norman Sachs; Pablo Secades; Laura van Hulst; Maaike Kreft; Ji-Ying Song; Arnoud Sonnenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-10       Impact factor: 11.205

7.  Epidermal α6β4 integrin stimulates the influx of immunosuppressive cells during skin tumor promotion.

Authors:  Samar W Maalouf; Surein Theivakumar; David M Owens
Journal:  J Dermatol Sci       Date:  2012-02-27       Impact factor: 4.563

8.  Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines.

Authors:  J Chad Brenner; Martin P Graham; Bhavna Kumar; Lindsay M Saunders; Robbi Kupfer; Robert H Lyons; Carol R Bradford; Thomas E Carey
Journal:  Head Neck       Date:  2010-04       Impact factor: 3.147

9.  Dual Role of alpha6beta4 integrin in epidermal tumor growth: tumor-suppressive versus tumor-promoting function.

Authors:  Karine Raymond; Maaike Kreft; Ji-Ying Song; Hans Janssen; Arnoud Sonnenberg
Journal:  Mol Biol Cell       Date:  2007-08-15       Impact factor: 4.138

Review 10.  Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets.

Authors:  Christopher S Stipp
Journal:  Expert Rev Mol Med       Date:  2010-01-18       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.